Niowave Expands Global Supply Agreement with AstraZeneca to Deliver Actinium-225 for Next-Generation Cancer Therapies
PR Newswire —
Niowave will expand its agreement to supply Actinium-225, a highly promising medical isotope, to AstraZeneca 10-year supply agreement will help advance new radioconjugate therapies capable of precisely targeting and destroying cancer cells LANSING, Mich., Dec. 18, 2025 /PRNewswire/ --...